Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.185
-0.055 (-4.44%)
At close: Jul 17, 2026, 4:00 PM EDT
1.220
+0.035 (2.95%)
After-hours: Jul 17, 2026, 7:55 PM EDT
Milestone Pharmaceuticals Market Cap
Milestone Pharmaceuticals has a market cap or net worth of $161.22 million as of July 17, 2026. Its market cap has decreased by -1.37% in one year.
Market Cap
161.22M
Enterprise Value
114.33M
1-Year Change
-1.37%
Ranking
Category
Stock Price
$1.19
ChartMarket Cap Chart
Since May 9, 2019, Milestone Pharmaceuticals's market cap has decreased from $363.46M to $161.22M, a decrease of -55.64%. That is a compound annual growth rate of -10.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 161.22M | -21.43% |
| Dec 31, 2025 | 205.20M | 31.26% |
| Dec 31, 2024 | 156.32M | 117.39% |
| Dec 29, 2023 | 71.91M | -57.49% |
| Dec 30, 2022 | 169.15M | -38.80% |
| Dec 31, 2021 | 276.39M | 38.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Outlook Therapeutics | 176.46M |
| Arcturus Therapeutics Holdings | 175.65M |
| YD Bio | 172.99M |
| Jyong Biotech | 170.74M |
| AN2 Therapeutics | 168.20M |
| Innate Pharma | 167.46M |
| Oramed Pharmaceuticals | 165.75M |
| OnKure Therapeutics | 165.62M |